Royalty Pharma plc (RPRX) Return on equity 2018–2025
Royalty Pharma plc (RPRX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
7.9%FY2025 · since FY2018: 30.3% → 7.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 7.9% | -0.4 pp |
| FY2024 | 8.3% | -2.9 pp |
| FY2023 | 11.3% | +10.8 pp |
| FY2022 | 0.4% | -5.6 pp |
| FY2021 | 6.0% | -3.8 pp |
| FY2020 | 9.9% | -28.4 pp |
| FY2019 | 38.2% | +8.0 pp |
| FY2018 | 30.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice